United States · FDA National Drug Code directory
Desvenlafaxine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51991-312_8e532045-4ca8-423d-a070-29b81fb0823f
- Product NDC
- 51991-312
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Desvenlafaxine Succinate
- Labeler
- Breckenridge Pharmaceutical, Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170301
- Source listing expiry
- 20271231
Source-listed ingredients
- DESVENLAFAXINE SUCCINATE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-312-01) · 51991-312-01
- 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-312-10) · 51991-312-10
- 100 TABLET, EXTENDED RELEASE in 1 CARTON (51991-312-11) · 51991-312-11
- 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-312-14) · 51991-312-14
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-312-33) · 51991-312-33
- 80 TABLET, EXTENDED RELEASE in 1 CARTON (51991-312-80) · 51991-312-80
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-312-90) · 51991-312-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →